Alnylam Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES

Last updated:

Abstract:

The invention relates to double-stranded ribonucleic acid (dsRNA) targeting an APOC3 gene, and methods of using the dsRNA to inhibit expression of APOC3.

Status:
Application
Type:

Utility

Filling date:

24 Jun 2021

Issue date:

17 Feb 2022